.svg){kind=small}
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the 2024 PNS Annual Meeting from 22nd to 25th June in Montreal, Canada. This event brings together global experts and specialists in peripheral neuropathy to discuss the latest advancements and research.
Attendees will include clinicians, researchers, and industry professionals dedicated to improving the understanding and treatment of peripheral nerve disorders.
If you would like to connect with Dr. Taubel during the event, please reach out to arrange a meeting.
To find out more, click here.
-min.jpg)
.jpg)
Latest news
Richmond promotes new Director of Communications and Participant Engagement
August 12, 2024
Richmond Pharmacology is delighted to announce the promotion of Liz Romano to the new position of Director of Communications and Participant Engagement.
Read moreRichmond Chief Medical Director calls for a ‘toolbox’ of standards and guidelines for clinical trials
August 5, 2024
The British Journal of Clinical Pharmacology has published an editorial by Richmond’s Dr Ulrike Lorch and Professor Charles Vincent of Oxford University calling for a ‘toolbox’ of practical standards and guidelines for early phase clinical trials.
Read moreEvents
21st DIA Japan Annual Meeting 2024
27 - 29 October 2024
Dr. Jörg Taubel, along with colleagues Nobuo Ittetsu and Minoru Takada, will be attending the 21st DIA Japan Annual Meeting 2024.
View event
